N/A
N=13
Effects of Adding Chickpeas to the American Diet on Fecal Microbiota Composition and Markers of Inflammation
Inflammation
Bottom Line
View on ClinicalTrials.gov: NCT02375347 ↗Enrolled (actual)
13
Serious AEs
0.0%
Results posted
May 2016
Primary outcome: Primary: Changes in Diversity of Gut Microbiota 16S rRNA Gene Sequences With Regard to Time. — 316.383; 302.400; 283.058 Avg. Operational Taxonomic Units
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Chickpea Enhanced Diet (Short term) (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Florida
- Primary completion
- Aug 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Changes in Diversity of Gut Microbiota 16S rRNA Gene Sequences With Regard to Time. |
316.383; 302.400; 283.058 | — |
Summary
This prospective study will assess the effects of adding legumes, especially chick peas, to the diet of healthy adults on the commensal bacteria from feces of human subjects and resulting self-reported GI symptoms as well as markers of immune function.
Eligibility Criteria
Inclusion Criteria
- Good Health
- No systemic antibiotics during the preceding two months
- No medication suppressing immune function
- Willingness to provide basic demographic as well as medical history data
Exclusion Criteria
- Gastric Ulcers
- Inflammatory Bowel Disease (IBD) or Irritable Bowel Syndrome (IBS)
- Chronic constipation/diarrhea
- Body Mass Index (BMI) > 30
- Dietary restrictions that prevent legume intake
- Currently on any medication that can affect GI transit time
- Consumption of >3 servings/week of chickpeas or >6 servings/week of legumes BEFORE study begins
Data sourced from ClinicalTrials.gov (NCT02375347). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.